MDLZ Mondelez International, Inc.
Food and Kindred Products · Nasdaq · SEC CIK 1103982 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.0%
TTM net income YoY15.5%
TTM EPS YoY19.1%
Revenue 3-yr CAGR4.1%
Net income 3-yr CAGR-3.9%
Margins
Gross margin34.3%
Operating margin13.7%
Net margin10.2%
FCF margin9.2%
EBITDA margin16.6%
Returns
ROE15.5%
ROA5.7%
ROIC (approx.)9.3%
Asset turnover0.56x
Leverage & solvency
Liabilities / assets62.9%
Debt / equity0.75x
Current ratio0.62x
Interest coverage9.21x
Cash quality & payout
Operating cash flow / net income1.23x
Accruals ratio-1.3%
Payout ratio63.1%
Capex / revenue3.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $38.54B | $36.44B |
| Cost of revenue | $27.60B | $22.18B |
| Gross profit | $10.94B | $14.26B |
| R&D expense | $400.00M | $400.00M |
| SG&A expense | $7.17B | $7.44B |
| Operating income | $3.55B | $6.34B |
| Interest expense | $599.00M | $508.00M |
| Pretax income | $3.01B | $6.26B |
| Income tax | $782.00M | $1.47B |
| Net income | $2.45B | $4.61B |
| EBITDA | $4.91B | $7.65B |
| EPS (basic) | 1.89 | 3.44 |
| EPS (diluted) | 1.89 | 3.42 |
| Dividends declared per share | 1.94 | 1.79 |
| Weighted avg. shares (diluted) | 1.30B | 1.35B |
| Balance sheet | ||
| Cash & equivalents | $2.19B | $1.40B |
| Receivables | $3.90B | $3.87B |
| Inventory | $4.42B | $3.83B |
| Current assets | $12.95B | $13.24B |
| PP&E, net | $10.67B | $9.48B |
| Goodwill | $24.34B | $23.02B |
| Intangibles | $19.63B | $18.85B |
| Total assets | $71.49B | $68.50B |
| Current liabilities | $21.86B | $19.55B |
| Short-term debt | $2.69B | $71.00M |
| Long-term debt | $17.22B | $15.66B |
| Total debt | $19.91B | $15.73B |
| Total liabilities | $45.60B | $41.54B |
| Shareholders' equity | $25.84B | $26.93B |
| Net debt | $17.71B | $14.34B |
| Cash flow statement | ||
| Operating cash flow | $4.51B | $4.91B |
| Capital expenditure | $1.28B | $1.39B |
| Free cash flow | $3.23B | $3.52B |
| Investing cash flow | -$1.20B | $526.00M |
| Financing cash flow | -$2.76B | -$5.78B |
| Depreciation & amortization | $1.36B | $1.30B |
| Stock-based compensation | $114.00M | $147.00M |
| Dividends paid | $2.49B | $2.35B |
| Share buybacks | $2.38B | $2.33B |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.